Real-world effectiveness of intravenous belimumab in adults with systemic lupus erythematosus: results of the observational OBSErve study in the Russian Federation.
第一单位:
Institute of Rheumatology by V.A. Nasonova, Russian Academy of Science, Moscow, Russian Federation.
作者:
DOI
10.1186/s41927-024-00452-0
PMID
39780259
发布时间
2025-01-11
- 浏览0

BMC rheumatology
2025年9卷1期
4页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文